FMC

FMC

Market cap $2.18B

FMC's CEO said between five and 10 parties were interested in buying the company. The war in Iran has also tightened supplies in the agricultural chemicals space.

FMC wins EU approval for Isoflex herbicide, unlocking access to more than 55 million hectares in a market lacking new crop protection solutions.

In February, FMC announced it would pursue strategic options. Revenue has been dropping.

There are reportedly up to 10 parties that may be interested in acquiring FMC. A deal, however, is by no means inevitable.

PHILADELPHIA, April 6, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced that Isoflex® active, the trade name for bixlozone, has received regulatory approval in the European Union (EU). This approval is a critical milestone in FMC's commercialization process, paving the way for the introduction of formulated products across more than 55 million planted hectares of cereals, corn, oilseed rape and potato in the EU.

FMC is benefiting from disruptions in shipments of fertilizer and other agricultural chemicals as a result of the war. FMC's CEO elaborated on potential buyout offers late last week.

NEW YORK, March 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of FMC Corporation ("FMC" or the "Company") (NYSE: FMC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of FMC Corporation (“FMC” or the “Company”) (NYSE: FMC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

PHILADELPHIA, March 24, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today it will release its first quarter 2026 earnings on Wednesday, April 29, 2026, after the stock market close via PR Newswire and the company's website https://investors.fmc.com. The company will host a webcast conference call on Thursday, April 30, 2026, at 9:00 a.m.

Patent cliff fears are priced in for FMC, while its new molecules pipeline shows strong growth potential ahead. Debt risk remains high, but strategic review and asset sales could unlock meaningful shareholder value.